📢 Our take on how ESOPEC and RENAISSANCE change the treatment landscape for gastroesophageal cancer Nice to write this for the #ASCO Daily News with Sam Klempner and Raghav Sundar 😊 dailynews.ascopubs.org/do/systemic-th…

Explore our Post-ASCO 2024 #GICancer Highlights 🔦 Lizzy Smyth, Samuel Klempner, Florian Lordick Top picks: 💡 ESOPEC: FLOT protocol vs CROSS protocol for adenocarcinoma 💡CheckMate 9DW: NIVO-IPI vs LEN/SOR for uHCC Explore all 👉 vjoncology.com/event/post-asc…

Building one of the largest datasets of gastric cancer peritoneal metastases in the world, we unravel new biology of organotropism, the important role of the tumor microenvironment and novel biomarkers. Just published in Gastroenterology! Joseph J Zhao gastrojournal.org/article/S0016-…

On the latest ESMO - Eur. Oncology #DailyReporter 📰 I'm giving a vision on key actions to tackle current cancer trends toward United Nations #SDGs and #UHC 🏆 See how 👩🏽‍⚕️ Shilpa Murthy & 🦸🏻‍♀️ Raffaella Casolino are making a difference in #globaloncology and #cancer care to all! The Lancet Oncology World Health Organization (WHO) 👇🏽👇🏽

Delighted to see my Georgian 🇬🇪 friends (and ESMO - Eur. Oncology mentee 😊) at #ESMOAcademy in Zurich this weekend. We had attendees from Europe 🇪🇺, Asia and even USA 🇺🇸 this year. Wishing you all the best luck 🍀🤞 in the #ESMO exam!

The DECIPHER #OesophagealCancer trial has just opened it's 10th site! 👏 Welcome to the #research team at the Royal Derby Hospital University Hospitals of Derby and Burton NHS FT. The trial is seeing if a targeted drug can improve outcomes for patients and stop the cancer returning👉 bit.ly/4cTFmLw

Really important result ⬇️ For high-risk stage II CRC, less is more...

#ESMO24: Do not miss the latest #CancerResearch brought to you by the #ESMOAmbassadors & become part of the conversation. 📌 ow.ly/PgWM50Th6Q3

It's nearly time...... #ESMO24 is here!! What's up in upper GI? See you on Saturday morning for these 🔥🔥🔥 topics! TOPGEAR - any role for RT in operable GEA? DESTINY Gastric 03 - where to next for TdXD in 1L HER2+ve GEA? Looking forward to seeing all ESMO - Eur. Oncology friends🤗

#ESMO24 starts tomorrow! Follow our updates as experts Lizzy Smyth and Sam Klempner provide their clinical takeaways on the latest data in upper GI cancer #MedEd #Oncology

What a pleasure and privilege to join with #ESMO24 Meeting Chair Rebecca Dent 👸 and incoming President FabriceAndre for #YOC leadership discussion. ➡️ Successful careers and leadership comes in all shapes and sizes. Stay strong ! 💪 ESMO - Eur. Oncology Rille

📢 Radiotherapy does not add to mFOLFIRINOX in borderline resectable #PancreaticCancer - ❎results for PRODIGE-44 #ESMO24 Good news for patients with PDAC - mFOLFIRINOX had ✅ outcomes (mOS 32.8m ➡️ 47.9m OS if resected). Results confirm ESMO - Eur. Oncology guidelines recommendations.

Time to move away from radiotherapy in operable GEA #ESMO24 TOPGEAR ➡️ no survival benefit when RT added to periop chemo TOPGEAR + ESOPEC : both great trials with a definitive answer = no more RT ✅Great drugs in development - let's focus on systemic Rx for cure ESMO - Eur. Oncology

Upper GI Orals at #ESMO24

At last - a new treatment for patients with advanced anal SCC #ESMO24 ➡️ Pod1um-303 shows 6m ⬆️ mOS for anti-PD-1 + chemo ESMO - Eur. Oncology Presidential 👏👏

Pleased to share final survival results of two phase 3 of zolbetuximab NEJM  which reinforce zolbetuxumab plus chemo as effective treatment option, though still need better treatment. More agents will be coming for CLDN18.2+ GC ESMO - Eur. Oncology OncoAlert #ESMO24 nejm.org/doi/full/10.10…

I'm excited to see this early data at #ESMO24 on AMG 193 for my patients with pancreas, biliary & oesophageal cancer 👏👏 MTAP deletion is a new target for hard to treat cancers annalsofoncology.org/article/S0923-… #Presidential ESMO - Eur. Oncology

#ESMOAmbassadors: We are excited to mark the first anniversary of this initiative at #ESMO24. ✨ Thanking the #ESMOAmbassadors for their stellar reporting during a year in life of the #OncologyCommunity 👏 — stay tuned.

It's a beautiful sunrise as we prepare to leave Barcelona after #ESMO24. Thanks to ESMO - Eur. Oncology Rebecca Dent Andres Cervantes Kate Kronig #ESMOAmbassadors for a super successful meeting!